Arimidex and Depression: An Overview
In clinical studies, up to 13 percent of women taking the drug reported depression as a side effect. This data comes from clinical trials that extensively studied Arimidex in thousands of people and documented its side effects. The challenge with Arimidex and depression, however, is that given how rarely depression is reported with the drug and how common it is within the general population (particularly in women with
breast cancer), it is difficult to tell whether depression is caused by Arimidex, other factors, or a combination of both.
Arimidex and Depression: Understanding Clinical Trials
Before most medicines are approved, they must go through several clinical studies where thousands of people are given a particular medicine and compared to a group of people not given the medicine. In these studies, side effects are always carefully documented. This way, it is possible to see what side effects occur, how often they appear, and how they compare to the group not taking the medicine.
However, sometimes it is unethical to not treat a condition. This is the case in cancer studies. Because it would be unethical to not treat breast cancer, Arimidex cannot be compared to a placebo ("sugar pill"). Therefore, it is difficult to tell if a side effect is due to Arimidex, other factors, or a combination of both.